Andrea De Micheli
Overview
Explore the profile of Andrea De Micheli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Livingston N, Kiemes A, Devenyi G, Knight S, Lukow P, Jelen L, et al.
Neuropsychopharmacology
. 2024 Apr;
49(9):1448-1458.
PMID: 38658738
Elevated hippocampal perfusion has been observed in people at clinical high risk for psychosis (CHR-P). Preclinical evidence suggests that hippocampal hyperactivity is central to the pathophysiology of psychosis, and that...
2.
Brodeur S, Oliver D, Ahmed M, Radua J, Venables J, Gao Y, et al.
Neurosci Biobehav Rev
. 2024 Apr;
161():105669.
PMID: 38599355
The effectiveness of universal preventive approaches in reducing the incidence of affective/psychotic disorders is unclear. We therefore aimed to synthesise the available evidence from randomised controlled trials. For studies reporting...
3.
Livingston N, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace A, et al.
Schizophr Bull
. 2024 Apr;
51(2):446-457.
PMID: 38567823
Background And Hypothesis: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences...
4.
De Micheli A, Provenzani U, Krakowski K, Oliver D, Damiani S, Brondino N, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540135
Background: The clinical high risk for psychosis (CHR-P) construct represents an opportunity for prevention and early intervention in young adults, but the relationship between risk for psychosis and physical health...
5.
Davies C, Martins D, Dipasquale O, McCutcheon R, De Micheli A, Ramella-Cravaro V, et al.
Mol Psychiatry
. 2024 Jan;
29(5):1241-1252.
PMID: 38243074
Abnormalities in functional brain networks (functional connectome) are increasingly implicated in people at Clinical High Risk for Psychosis (CHR-P). Intranasal oxytocin, a potential novel treatment for the CHR-P state, modulates...
6.
Livingston N, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace A, et al.
medRxiv
. 2023 Aug;
PMID: 37645948
Background: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences the risk...
7.
Oliver D, Davies C, Zelaya F, Selvaggi P, De Micheli A, Catalan A, et al.
Front Psychiatry
. 2023 Mar;
14:1092213.
PMID: 36970257
Introduction: The impact of the clinical high-risk for psychosis (CHR-P) construct is dependent on accurately predicting outcomes. Individuals with brief limited intermittent psychotic symptoms (BLIPS) have higher risk of developing...
8.
De Micheli A, Provenzani U, Solmi M, Van Pabst A, Youssef E, McGuire P, et al.
Schizophr Res
. 2023 Feb;
254:109-115.
PMID: 36827942
Several hypotheses have been proposed to explain why individuals with psychosis consume more tobacco compared with the general population, but the reasons remain unclear. The phases predating the onset of...
9.
Provenzani U, De Micheli A, Damiani S, Oliver D, Brondino N, Fusar-Poli P
Brain Sci
. 2023 Jan;
13(1).
PMID: 36672109
Background: The clinical high risk for psychosis (CHR-P) phase represents an opportunity for prevention and early intervention in young adults, which also could focus on improving physical health trajectories. Methods:...
10.
Estrade A, Spencer T, De Micheli A, Murguia-Asensio S, Provenzani U, McGuire P, et al.
Front Psychiatry
. 2023 Jan;
13:945505.
PMID: 36660464
Introduction: Indicated primary prevention of psychosis is recommended by NICE clinical guidelines, but implementation research on Clinical High Risk for Psychosis (CHR-P) services is limited. Methods: Electronic audit of CHR-P...